Mabel Teng
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
-
- Single-cell and spatial transcriptomics 3
- Metabolism, Diabetes, and Cancer 2
- Co-authors
- Philip J. Johnson (11 shared papers)Sarah Berhane (10 shared papers)Chiaki Kagebayashi (5 shared papers)Shinji Satomura (6 shared papers)Daniel H. Palmer (3 shared papers)Helen L. Reeves (2 shared papers)Toshifumi Tada (4 shared papers)Hidenori Toyoda (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)British Journal of Cancer (4 papers)Nature Methods (2 papers)Journal of Hepatology (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)
- Partner nations
- United KingdomJapanHong Kong
In The Last Decade
Mabel Teng
21 papers receiving 3.6k citations
Mabel Teng's Hit Papers
Peers
Comparison fields: 5 of 98
- Hepatology 1.6k
- Cancer Research 527
- Biophysics 139
- Epidemiology 653
- Oncology 433
Countries citing papers authored by Mabel Teng
This map shows the geographic impact of Mabel Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel Teng more than expected).
Fields of papers citing papers by Mabel Teng
This network shows the impact of papers produced by Mabel Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel Teng. The network helps show where Mabel Teng may publish in the future.
Co-authors
The 25 scholars most cited alongside Mabel Teng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade Hit paper breakdown → | 2014 | 1837 |
| 2 | G&T-seq: parallel sequencing of single-cell genomes and transcriptomes Hit paper breakdown → | 2015 | 536 |
| 3 | Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity Hit paper breakdown → | 2016 | 514 |
| 4 | 2013 | 240 | |
| 5 | 2016 | 110 | |
| 6 | 2007 | 100 | |
| 7 | 2011 | 66 | |
| 8 | 2011 | 62 | |
| 9 | 2017 | 45 | |
| 10 | 2014 | 41 | |
| 11 | 2011 | 23 | |
| 12 | 2014 | 23 | |
| 13 | 2012 | 10 | |
| 14 | 2022 | 10 | |
| 15 | 2014 | 8 | |
| 16 | 2014 | 8 | |
| 17 | 2004 | 5 | |
| 18 | 2004 | 2 | |
| 19 | 2014 | 2 | |
| 20 | 2013 | 1 |
About Mabel Teng
Mabel Teng is a scholar working on Hepatology, Molecular Biology, Cancer Research, Surgery and Epidemiology, having authored 21 papers that have together received 3.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (3 papers), Single-cell and spatial transcriptomics (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer, Lipids, and Metabolism (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Hepatology (1.6k citations), Cancer Research (527 citations), Biophysics (139 citations), Epidemiology (653 citations) and Oncology (433 citations). Mabel Teng has collaborated with scholars based in United Kingdom, Japan and Hong Kong. Frequent co-authors include Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi, Shinji Satomura, Daniel H. Palmer, Helen L. Reeves, Toshifumi Tada, Hidenori Toyoda, Takashi Kumada and Richard Fox. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Nature Methods, Journal of Hepatology and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.